scholarly journals Immunomodulating peptides derived from different human endogenous retroviruses (HERVs) show dissimilar impact on pathogenesis of a multiple sclerosis animal disease model

2018 ◽  
Vol 191 ◽  
pp. 37-43 ◽  
Author(s):  
Shervin Bahrami ◽  
Elzbieta Anna Gryz ◽  
Jonas Heilskov Graversen ◽  
Anne Troldborg ◽  
Kristian Stengaard Pedersen ◽  
...  
2021 ◽  
Author(s):  
Penelope Pfeiffer ◽  
Joan R Coates ◽  
Andrew Kennedy ◽  
Kyleigh Getchell ◽  
Edina Kosa ◽  
...  

Blood-based biomarkers are much-needed diagnostic and prognostic tools for ALS. Canine degenerative myelopathy (DM) is recognized animal disease model to study the biology of human ALS. Serum derived exosomes are potential carrier that transport intercellular hormone-like messengers, together with their stability as carrier of proteins and RNA, make them ideal as biomarkers for a variety of diseases and biological processes. We study exosomal TDP-43 pattern as a surrogate biomarker that reflects biochemical changes in central nervous system. We isolated exosomes from canine serum using commercial exosome isolation reagents. TDP-43 and SOD1 profile in spinal cord homogenate lysate and that of serum-derived exosomes were found elevated in dogs with DM. We conclude levels of spinal cord TDP-43 and serum-derived exomes were similar in TDP-43 profiling, which warrant further investigation of disease sensitivity and specificity for establishing as a blood-based biomarker in canine DM.


2018 ◽  
Vol 56 (4) ◽  
pp. 2590-2605 ◽  
Author(s):  
Gerwyn Morris ◽  
Michael Maes ◽  
Marianna Murdjeva ◽  
Basant K. Puri

2019 ◽  
Vol 2019 ◽  
pp. 1-13
Author(s):  
Xiaoli Huang ◽  
Yang Feng ◽  
Hong Tang ◽  
Guanqing Xiong ◽  
Liangyu Li ◽  
...  

Most species of the genus Elizabethkingia are pathogenic to humans and animals, most commonly causing meningitis. However, our understanding of the pathogenic mechanisms involved is poor and there have been few pathological studies of Elizabethkingia spp. in animals. To understand the host injury induced by Elizabethkingia spp., we established a model of E. miricola infection in the black-spotted frog (Pelophylax nigromaculatus). The systematic pathology in and oxidative damage in the infection model were investigated. Our results show that recently isolated E. miricola is a bacterium that mainly parasitizes the host brain and that neurogenic organs are the predominant sites of damage. Infection mainly manifested as severe brain abscesses, meningoencephalitis, necrotic spondylitis, and necrotic retinitis. The liver, spleen, kidney, gastrointestinal tract, and lung were also affected to varying degrees, with bacterial necrotic inflammation. P. nigromaculatus also suffered enormous damage to its oxidative system during E. miricola infection, which may have further aggravated its disease state. Our results provide a preliminary reference for the study and treatment of Elizabethkingia spp.-induced neurological diseases in animals.


PLoS ONE ◽  
2017 ◽  
Vol 12 (2) ◽  
pp. e0172415 ◽  
Author(s):  
Elena Morandi ◽  
Radu Tanasescu ◽  
Rachael E. Tarlinton ◽  
Cris S. Constantinescu ◽  
Weiya Zhang ◽  
...  

2009 ◽  
Vol 15 (4) ◽  
pp. 443-447 ◽  
Author(s):  
M Saresella ◽  
A Rolland ◽  
I Marventano ◽  
R Cavarretta ◽  
D Caputo ◽  
...  

Background Human endogenous retroviruses are suggested to play a pathogenic role in multiple sclerosis (MS); one of such retroviruses, the MS-associated retroviral agent (MSRV) has repeatedly been isolated in MS patients. Objective and methods We analyzed cytokine profiles in MSRV envelope protein (MSRV ENV-SU)-stimulated peripheral blood mononuclear cells of 30 relapsing-remitting MS patients with either acute (AMS) ( n = 13) or stable (SMS) ( n = 17) disease. Results suggest that MSRV ENV-SU induces the production of inflammatory cytokines, including tumor necrosis factor-α ( P < 0.05) and interferon-γ ( P < 0.004) in AMS patients and of interleukin-10 ( P < 0.05), an inflammation-dampening cytokine, in SMS individuals. Conclusions These data strengthen the hypothesis indicating that MSRV could be involved in the pathogenesis of MS.


2013 ◽  
Vol 20 (2) ◽  
pp. 174-182 ◽  
Author(s):  
Giannina Arru ◽  
Stefania Leoni ◽  
Maura Pugliatti ◽  
Alessandra Mei ◽  
Caterina Serra ◽  
...  

Background: Several viruses were reported as co-factors triggering the pathogenesis of multiple sclerosis (MS), including the endogenous retroviruses of the HERV-W family, that were also proposed as biomarkers of disease progression and therapy outcome. Objective: The objective of this article is to clarify whether in MS patients treatment with natalizumab has effects on MSRV/syncytin-1/HERV-W expression and the possible relationship with disease outcome. Methods: Peripheral blood mononuclear cells were collected from 22 patients with relapsing–remitting disease, at entry and after three, six and 12 months of treatment with natalizumab. The cell subpopulations and the expression of MSRV env/syncytin-1/HERV-W env were analyzed by flow cytometry and by discriminatory env-specific RT-PCR assays. Results: By flow cytometry the relative amounts of T, NK and monocyte subpopulations were shown to remain fairly constant. A relative increase of B lymphocytes was observed at three to six months ( p = 0.033). The MSRV env and syncitin-1 transcripts were reduced at six to 12 months of therapy ( p = 0.0001). Accordingly, at month 12, the plasma-membrane levels of the HERV-W env protein were reduced ( p = 0.0001). B cells, NK and monocytes but not T cells expressed the HERV-W env protein. None of the patients relapsed during therapy. Conclusion: Effective therapy with natalizumab downregulates MSRV/syncytin-1/HERV-W expression.


Sign in / Sign up

Export Citation Format

Share Document